Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Can liaison neurology add value to patient care within a mental health setting?

Ward JH. et al, (2025), Br J Psychiatry, 226, 47 - 48

GRIN2A (NR2A): a gene contributing to glutamatergic involvement in schizophrenia.

Harrison PJ. and Bannerman DM., (2023), Mol Psychiatry

Neuropsychiatric disorders following SARS-CoV-2 infection

HARRISON P. and Taquet M., (2023), Brain

Little evidence supports gabapentinoid use in bipolar disorder or insomnia

Saul H. et al, (2022), BMJ (Clinical research ed.), 379

New drug targets in psychiatry: Neurobiological considerations in the genomics era.

Harrison PJ. et al, (2022), Neurosci Biobehav Rev, 139

Response to the letter by Lin et al.

Taquet M. et al, (2022), Brain Behav Immun, 104

Load More